BRCA2 Polymorphism and Breast Cancer Risk
Author Information
Author(s): Gochhait Sailesh, Bukhari Syed Irfan Ahmad, Bairwa Narendra, Vadhera Shivani, Darvishi Katayoon, Raish Mohammad, Gupta Pawan, Husain Syed Akhtar, Bamezai Rameshwar NK
Primary Institution: National Centre of Applied Human Genetics, Jawaharlal Nehru University
Hypothesis
Can variants of genes involved in the same pathway influence the risk of breast cancer?
Conclusion
The -26 5' UTR polymorphism in BRCA2 can modulate breast cancer risk based on genotype status.
Supporting Evidence
- The A allele of the -26 G>A polymorphism increased reporter gene expression in cell lines.
- Heterozygous genotype was found to be protective against breast cancer.
- The p53 codon 72 Arg homozygous genotype was over-represented in patients.
- Simultaneous presence of protective genotypes provided fivefold protection against breast cancer.
Takeaway
Some people have a change in their genes that can help protect them from getting breast cancer, while others might be at higher risk.
Methodology
A case-control study was conducted with 576 individuals, using luciferase reporter assays and RNA secondary structure analysis.
Potential Biases
Potential bias due to the case-control design and population specificity.
Limitations
The study is limited to a specific population in north India, which may not be generalizable.
Participant Demographics
243 patients with sporadic breast cancer and 333 healthy female controls from north India.
Statistical Information
P-Value
0.0005
Confidence Interval
0.4 to 0.8
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website